SanguisAI logo — Diagnosing anaemia; non-invasively, inexpensively, and fast.

SanguisAI

Diagnosing anaemia; non-invasively, inexpensively, and fast.

Founded 2021 The Netherlands The Netherlands 3 employees Grant Total: $19.20K Health Care, Health and Wellness +1

General Information

Company Name SanguisAI
Founded Year 2021
Location The Netherlands The Netherlands
Employees 3
Industries Health Care, Health and Wellness, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with SanguisAI. To contact SanguisAI, visit sanguisai.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About SanguisAI

SanguisAI is a healthcare startup based in The Netherlands, founded in 2021. Their slogan, "Diagnosing anaemia; non-invasively, inexpensively, and fast," encapsulates their mission. The company is tackling the global issue of anaemia, which affects 1 in 4 people and is the leading cause of burden-free years lost worldwide, as stated by the World Health Organization. SanguisAI's innovative approach involves developing clip-on devices that enable consumers and medical service providers to measure haemoglobin without invasive and costly blood draws. This solution aims to address the current challenges of slow, invasive, and specialized procedure required for diagnosis. Their last investment, a €19.20K grant investment, was secured on 08 September 2022 from Massachusetts Institute of Technology. The technology and service SanguisAI offers align with the growing demand for non-invasive and cost-effective healthcare solutions.

Taxonomy: Medical devices, Hemoglobin measurement, Anemia diagnosis, Blood count monitoring, Non-invasive diagnostics, Consumer health products, Medical service providers, Philadelphia, Biomedical technology, Global health, Public health innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €19.20K 1
Massachusetts Institute of Technology
08 Sep 2022

SanguisAI Alternatives & Competitors

SanguisAI vs
OrSense
OrSense Israel

OrSense is a medical device company developing and marketing non-invasive monitoring systems for mea...

Series H
23 employees
Health Care, Medical Devices
SanguisAI vs

The leading technology for continuous non-invasive blood pressure measurement, autonomic testing and...

16 employees
Health Care, Medical Devices
SanguisAI vs
Sanguina, Inc.
Sanguina, Inc. United States

Wellness At Your Fingertips

Series A
17 employees
Health Care, Medical Devices

FAQ About SanguisAI

Diagnosing anaemia; non-invasively, inexpensively, and fast.
SanguisAI was founded in 2021.
SanguisAI is headquartered in The Netherlands.
SanguisAI operates in Health Care, Health and Wellness and Medical Devices. Its work centres on Medical devices, Hemoglobin measurement, Anemia diagnosis and Blood count monitoring.
SanguisAI has approximately 3 employees.
SanguisAI has completed 1 funding round, raising a total of $19.20K. The latest funding stage is Grant.
Top alternatives and competitors to SanguisAI include OrSense, Finapres Medical Systems, Sanguina, Inc., SunTech, Sanolla. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SanguisAI and OrSense are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SanguisAI, https://bouncewatch.com/company/sanguisai, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes